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Biocontainment comprises any strategy applied to ensure that harmful organisms are con-
fined to controlled laboratory conditions and not allowed to escape into the environment.
Genetically engineered microorganisms (GEMs), regardless of the nature of the modification
and how it was established, have potential human or ecological impact if accidentally leaked
or voluntarily released into a natural setting. Although all evidence to date is that GEMs are
unable to compete in the environment, the power of synthetic biology to rewrite life requires
a pre-emptive strategy to tackle possible unknown risks. Physical containment barriers have
proven effective but a number of strategies have been developed to further strengthen bio-
containment. Research on complex genetic circuits, lethal genes, alternative nucleic acids,
genome recoding and synthetic auxotrophies aim to design more effective routes towards
biocontainment. Here, we describe recent advances in synthetic biology that contribute to
the ongoing efforts to develop new and improved genetic, semantic, metabolic and mech-
anistic plans for the containment of GEMs.
Introduction – what’s the risk?
We have altered our environment throughout history. We have domesticated animals and plants, we have
invented ever more sophisticated tools, and we have harnessed nearly every possible resource available on
Earth to ensure our continued survival and fuel our evolving needs and lifestyles – not always ethically,
not always sustainably, rarely understanding or minimizing the impact of our actions.
We are now at a point where our knowledge and technology enable us to change biology into a tool
itself – the first tool that can exceed its own design parameters as life can repair itself, multiply, evolve
and potentially escape. A tool escaping implies the potential entry of engineered organisms (or engi-
neered genetic information) into the environment, and a possible detrimental impact on the environment,
whether direct (e.g. competing with natural species) or indirect (e.g. changing the balance between native
species). The potential environmental effect of genetically modified organisms (GMOs) has been a long-
standing concern for scientists and a regular topic of discussion since the dawn ofmolecular biology in the
mid-1970s [1,2].
The consensus approach is containment – any strategy that can be deployed to prevent GMOs (or their
genetic information) from escaping the controlled experimental environment. Containment is under-
pinned by our understanding of risk and by the tools available to implement it.
In its most basic definition, risk is the probability of a known possible event. Complex situations, where
probabilities may not be determined or where we cannot foresee every possible event, undermine the
reliability of risk estimation [3]. It affects our judgement of a situation that becomes increasingly subjective
and may account for some of the disparity in acceptance of GMOs seen across societies.
Lack of specific knowledge is not an impediment if pre-emptive action can be taken to address the
sources of potential risk. For instance, althoughwemay not be able to foresee how everyGMOcan interact
with the environment and how likely those scenarios are, we can still tackle its potential sources of risk to
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Figure 1. Routes to biological containment
Strategies to prevent the escape of GEMs can be broadly divided between changes to the manufacturing of biological products, changes to
individual components or changes to biological processes themselves.Within each approach, different strategies are ranked by the expected
engineering challenge to implement them in bacteria (yellow-to-blue scale for increasing engineering challenge). Compartmentalization
[21–23] and cell-free systems [24,25] are not covered in this review.
the environment, i.e. GMOs interacting with the environment as organisms or the information coded by the GMO
(e.g. antibiotic resistance [4]) being passed onto the environment.
Containment naturally emerges from that framework and its goals are clear: avoid, prevent and minimize – avoid
known traits that are likely to benefit GMOs in the natural environment, prevent GMOs from entering the envi-
ronment and minimize any potential penetration into the environment. The same criteria are also applicable to any
genetic information used in engineering an organism since exchange and acquisition of genetic information, better
known as horizontal gene transfer, particularly for microorganisms, is common in the environment [4,5].
This review focuses on the biological containment of genetically engineered microorganisms (GEMs) and, in par-
ticular, on recent synthetic biology developments that have the potential to greatly enhance containment standards.
This being a short review, we apologize to colleagues whose work we did not include and our aim is to complement
a number of excellent recent reviews on biological containment [2,5–9].
Established containment strategies
A number of strategies have been implemented over the years to establish biological containment, which is described
as successful if the probability of an organism bypassing the containment measures drops below 10-8 [1,10,11] – that
is, recovering fewer than 102 CFU from a 100 mL culture at O.D.600 of 1 (given a microorganism for which an O.D.600
of 1 equates to 108 CFU/mL).
The current gold standard in containment, as it is implemented for the industrial-scale production of microor-
ganisms (andmicroorganism-derived products), is achieved by the design of physical barriers. Engineering design of
equipment, process and production plant all contribute to the containment of GEMs [12], as shown in Figure 1.
In addition to physical measures, containment can be achieved through biological means. The three most estab-
lished strategies are based on inducible systems, auxotrophy and cellular circuits [13]. Crucially, no single strategy
used in isolation has delivered, to date, successful containment [5].
Inducible systems, the least effective route towards containment, include well-characterized gene expression plat-
forms widely used in molecular biology (e.g. tetracycline promoter regulation with anhydrotetracycline [14]). Con-
tainment is achieved by the requirement of an inducer of gene expression not common in the environment. Thus,
the engineered traits are displayed only in the controlled growth environment of the lab when the inducer is present.
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Outside that environment, the engineered trait is not displayed and cells lose any potential advantage granted by the
inducible system.
Auxotrophy removes the ability of the organism to synthesize a vital compound that must be acquired from the
growth media or the environment. Most bacterial laboratory strains have some form of auxotrophy, which reduces
their fitness and contributes to containment in the laboratory setting. Targeting compounds central for cell survival
and that are required in high concentrations maximize the effectiveness of the approach, e.g. thymine in thyA- mu-
tants [15–17]. Notably, inducible systems or auxotrophy do not address the potential risk of genetic information
escape, i.e. horizontal gene transfer.
Cellular circuits include kill switches as well as addiction modules, all achieving containment by making cells de-
pendent on a compound (or lack thereof) or particular genetic information. Kill switches are genetic circuits that once
activated lead to cell death, such as through the expression of the membrane-disruptive proteins of the Hok family
[18].
These circuits can be used in a number of different topologies enabling complex logic circuits to be built that require
particular combinations of inputs for cell survival [19,20].
Addictionmodules, or toxin-antitoxin systems, in contrast, consist of a combination of stable toxin and an unstable
antitoxin (reviewed by Hayes [26]) with cell survival balanced between the production and degradation of both. For
containment, toxin and antitoxin genes can be placed in different parts of the cell’s genetic repository, e.g. with the
toxin on the plasmid and antitoxin on the genome. Such arrangement ensures that in case of horizontal gene transfer,
the plasmid carries the toxin but not the antitoxin, killing the new host and limiting the penetration of any genetic
information stored in the plasmid.
Complex biological containment circuits
Used in isolation or reliant on a single target, the more established containment strategies are not sufficient to prevent
escape because of the low evolutionary cost of bypassing or reverting the containment mechanism. For instance,
most containment circuits developed by Chan and colleagues consisting of a single toxin [20], did not achieve escape
frequencies of less than 10-6, with mutation of the lethal actuator being one of the main sources of escape.
The evolutionary cost of escape can be increased, and with it the efficacy of containment, by combining multiple
targets or containment strategies – each individual measure described as a layer of containment. Chan and colleagues
did this by introducing two different lethal actuators and pushing escape frequencies below 10-8 even after 4 days
[20]. Crucially, although layers of containment are additive, they do not show synergism.
In another example ofmulti-layered containment,Wright and colleagues developed a complex circuit (GeneGuard)
that relies on conditional origins of replication, auxotrophy and an addictionmodule for containment [27]. TheGene-
Guard circuit is split between a genomic and a plasmid module, ensuring inter-dependence of plasmid and host (the
plasmid requires a genomic factor for replication, the host requires auxotrophic supplementation from the plasmid)
and minimizing information escape (the plasmid harbours toxin of the addiction module). The work demonstrates
that each factor contributes to containment but it is less clear whether together they would reach a deemed safe level
of containment (see above).
Gallagher and colleagues also pursued a multifactor approach to containment, integrating riboregulators (requir-
ing multiple inputs to allow translation of essential genes), engineered addiction modules (based on nuclease and
methylase systems), auxotrophy and supplemental repressors (to further limit systemmis-activation by increasing its
silencing) [28]. A strain engineered with a four-layer containment demonstrated robust long-term containment with
escape frequencies of less than 2 x 10-12 – the lowest reported to date.
Engineering further containment: trophic
containment
Biology is not limited by what is natural, but rather, by what is possible. As such, it is feasible to engineer novel
approaches for containment that exploit alternative core biological processes, including metabolism, translation and
genetic information storage.
Metabolic containment, in which the organism depends on the supply of a metabolite for survival, is exemplified
by auxotrophism (detailed above). A key shortcoming of auxotrophism however, is that metabolites are generally
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commonbetweenmany organisms and can thus be found in the natural environment, togetherwith the genes for their
biosynthesis. Nevertheless, this approach can be extended by creating organisms that require synthetic compounds
for survival. Because these synthetic cofactors are not available in nature, containment of such a synthetic auxotroph
should outperform the usual auxotrophic barriers.
Non-canonical amino acids (ncAAs) have recently been reported as viable synthetic cofactors by two groups. Lajoie
and colleagues built a synthetic Escherichia coli auxotroph by engineering six essential genes (adk, alaS, holB,metG,
pgk and tyrS) to depend on the ncAA L-4,4’-biphenylalanine (BFA). Computer-assisted protein engineering was
used to identify sites in essential proteins where hydrophobic cores could be engineered to require BFA, which differs
significantly in size and geometry from the canonical set of amino acids. Starting from an E. coli strain devoid of
amber stop codons [29], BFA was added to the genetic code of the host through an engineered transfer ribonucleic
acid (tRNA) and aminoacyl-tRNA synthetase pair targeted to amber codons [30]. As with other strategies, a single
containment layer did not provide escape frequencies below 10-8, especially in extended culture conditions (7 days).
Once multiple dependencies were created however, escape frequencies rapidly dropped below 2 x 10-12, their limit of
detection, even after 14 days.
Using an analogous approach (i.e. using engineered genomic amber sites to target ncAA incorporation into es-
sential genes), Rovner and colleagues explored a small number of strategies to identify suitable target sites for ncAA
incorporation. In addition to computer-assisted design, they also targeted residues proximal to the N-terminus and in
the active site of essential host factors [31]. The result was also the isolation of strains that in the presence of multiple
containment layers had escape frequencies below 10-8 even after prolonged culture.
However, ncAAs are not the only viable synthetic cofactors. Allosteric regulation of enzymes through small
molecules is widely present in biology [32], can be exploited with synthetic compounds [33] and can also be en-
gineered [34,35]. Building on the work of Deckert and colleagues [35], Lopez and Anderson established a directed
evolution platform (SLiDE – synthetic auxotrophs based on ligand-dependent essential genes) for the selection of
engineered E. coli essential proteins that require external complementation from small molecules [36].
Using SLiDE, Lopez and Anderson engineered an E. coli BL21 strain with three essential genes (tyrS, metG, pheS)
dependent on benzothiazole for function. The approach is scalable and as the authors point out, considerably cheaper
than whole genome recoding. The escape frequency of the triple mutant was below detection (less than 3 x 10-11) but
rose to around 10-6 after a couple of days. Still, SLiDE could be used to target more than three genes or to rely on
chemical compounds that are structurally or chemically more distant from biological metabolites. Interestingly, there
are now reports that sites for allosteric regulation may be structurally conserved between homologous proteins [37],
allowing developments made in model organisms to be rapidly adapted to other industrially relevant species.
In theory, containment by auxotrophy can be extended beyond chemical supplementation, with hosts being engi-
neered not only to rely on a synthetic cofactor but also to have a syntheticmetabolism, which could conceivably create
a barrier to information transfer between organism and biology. If the engineeredmetabolismdiffers sufficiently from
the natural system, they could become incompatible leading to the accumulation of undesired intermediates or even
toxic compounds in a natural host.
Some proteins naturally require cofactors, such as specific metal ions, vitamins and redox centres. In principle,
it should also be possible to engineer these proteins to depend on alternative cofactors, developing a new class of
synthetic auxotrophs. Metalloprotein engineering has come closest to this approach, creating the environment for
non-biological chemistries and raising the possibility of introducing those in vivo [38–40].
Nevertheless, containment would require those reactions to be linked to the organism’s core metabolism to cement
the auxotrophic requirement; an idea explored by the UCL iGEM 2014 team with synthetic quinones [41]. Quinones
have a central role in the transport of electrons across membranes and therefore in the energy metabolism of the cell.
The team proposed that host factors could be engineered to depend on synthetic quinone-like compounds; an idea
that has not yet been explored further.
Engineering further containment: semantic
containment
While genetic circuits and trophic containment can be effective strategies to stop GEMs from proliferating into the
environment, they do less to prevent the escape of the engineered genetic information. For that, the information itself
has to be altered – making the genetic code and genetic information storage important targets for containment.
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Figure 2. Changing the genetic code for semantic containment
Any change in the genetic code – sense-to-sense, sense-to-stop or triplet-to-quadruplet (see orthogonal translation as a containment
strategy section) – leads to the incorporation of a different amino acid (Xxx) or protein synthesis termination (RF – release factor). As a result,
the same messenger RNA (mRNA) message leads to two different proteins under the natural and engineered code. If the reassignment is
sufficiently disruptive, such that under the natural code the resulting protein is not functional, then information cannot move from engineered
to natural organism.
The genetic code is universal (barring a few minor exceptions) hence, in principle, genetic information can be
translated into the same protein regardless of the host organism. Containment emerges if an engineered organism
can operate under a different genetic code, either through codon reassignment or by altering the decoding rules – see
Figure 2. Such an altered code changes the meaning of the genetic information, ensuring functional proteins could
only be functional in the engineered host – making the information itself semantically contained.
Codon assignment is primarily established by the specificity of aminoacyl-tRNA synthetases (aaRS) and their cog-
nate tRNAs but further enforced by a number of cellular factors such as additional proofreading proteins [42–47],
elongation factors and the ribosome itself [48]. Codon reassignments can take three routes – sense-to-stop, stop-to-
sense and sense-to-sense replacements – with modifications of aaRS/tRNA pairs an efficient route towards creating
any alternative code [49].
Stop-to-sense codon reassignment, also termed stop codon suppression, occurs naturally in organisms harbouring
tRNAs that have evolved to recognize stop codons. When transcribed, those tRNAs – known as suppressor tRNAs
– compete with release factors binding the ribosome, delivering an amino acid that is incorporated into the nascent
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
397
Essays in Biochemistry (2016) 60 393–410
DOI: 10.1042/EBC20160013
polypeptide and allowing translation to continue [50]. Stop codon suppression has been very successfully exploited
to expand the genetic code, enabling the incorporation of a large number of ncAAs through the engineering of aaRS
and cognate tRNA that can specifically charge the desired ncAA but that do not interfere with the cellular aaRS or
tRNAs (i.e. an orthogonal aaRS/tRNA pair) [45–47].
Still, the competition between stop codon suppression and termination is usually biased towards the highly effi-
cient canonical processes, resulting in poor ncAA incorporation and creating a bottleneck for the large-scale synthesis
of ncAA-containing engineered proteins [45–47]. Deletion of release factor 1 (RF1) in E. coli, which is possible be-
cause of partial redundancy with RF2, significantly improves stop codon suppression and increases ncAA-containing
protein yields [51,52].
Stop codon reassignment within an essential gene (for the incorporation of natural amino acids) is, in principle,
enough to provide containment, since in the absence of a charged suppressor tRNA, the engineered information
cannot be effectively translated and the host dies. Nevertheless, containment can be further improved by placing the
stop codon at a site relevant for protein function where the amino acid being introduced cannot be easily substituted.
Using ncAAs not abundant or not present in nature can add a further layer of containment, since in addition to the
semantic barrier, an auxotrophic barrier is created, with very promising results [31,53] – see above.
Sense-to-sense reassignment can also be used to establish biological containment, but this strategy has not yet been
as widely explored. Such reassignment does not have to be direct and can be implemented via sense → stop → sense
reassignments – with the recent removal of multiple codons from E. coli [54] an intermediate in that process. Any
change to the genetic code affects the host’s fitness, thus, the engineering challenge increases with the frequency of
codon exchanges across a genome. Amber stop codons (TAG), described above for stop codon suppression, occur
only 321 times in the E. coli genome, and its suppression or reassignment causes minimal impact on cell fitness [52].
Sense codons are naturally more frequent (e.g. 4228 instances of AGG/AGA in the E. coli genome; [55]). Hence,
unless the synthesis of tailored proteins cannot be engineered to work in parallel with the main cellular processes
(e.g. either through compartmentalization, like expression in microalgae chloroplasts [56], or by introduction of a
completely orthogonal translation system), reassigning sense codons will lead to an experimental intermediate where
the code has at least one degeneracy; meaningmore than one aaRS/tRNA pair targeting the incorporation of different
amino acids at the same codon. Degeneracy of the genetic code can be advantageous in some circumstances [57], but
would more probably lead to protein misfolding and thereby increased burden on the host – the underlying principle
of semantic containment.
This presents two alternative approaches to pursue sense-to-sense reassignment: engineer the host to pre-emptively
remove degeneracies, or exploit acceptable or transient degeneracies to develop the code. Lajoie and colleagues have
demonstrated that rare codons in E. coli can be removed from essential genes [52] and have more recently demon-
strated that it is possible to scale that process up to large sections of the genome [54], freeing up seven codons that
can be reintroduced as novel amino acids or stop codons.
Some degeneracy can be tolerated by the cell sufficiently for it to be of use in the engineering of the genetic code,
particularly if the recoding is required for cell survival. For instance, Do¨ring and Marlie`re probed if cysteine could
invade isoleucine and methionine codons by introducing tRNACys variants modified in their anticodon sequences
[58]. They coupled the resulting genetic code degeneracy to amutant ThyA (thymidylate synthetase), with its catalytic
cysteine miscoded in the gene. The result demonstrated that all four anticodon variants could support functional
ThyA synthesis, and therefore cell survival in growth media lacking thymine, when the anticodon and engineered
codon matched. Interestingly, on removal of the selective pressure, the degeneracy persisted for over 500 generations
before dropping to below 1% of the population – highlighting that the degeneracy (e.g. AUC → I/C) generated only
minimal toxicity.
Other acceptable degeneracies have been reported, such as phenylalanine and 3-(2-naphthyl)-L-alanine [59], or
arginine (rare codon AGG) and L-homoarginine [60]. Both teams introduced orthogonal aaRS/tRNA pairs with im-
proved anticodon-codon affinities in E. coli (Watson–Crick pairing rather than wobble in the codon-anticodon),
thereby outcompeting the natural codon assignment [59] – which can be further fine-tuned by altering host tRNA
levels. Mukai and colleagues further minimized the impact of the recoding of arginine to L-homoarginine by mak-
ing the reassignment temperature dependent and by recoding 38 AGG to other arginine codons in 32 essential genes
[60].More frequent codons can also be reassigned using a similar strategy. Ho and colleagues invaded both serine and
leucine codonswith an engineered pyrrolysyl-tRNA synthetase capable of charging the ncAA3-iodo-L-phenylalanine
to its cognate tRNA [61].
In an alternative strategy, Hoesl and colleagues used serial passaging to systematically replace tryptophan with L-
beta-(thieno[3,2-b]pyrrolyl)alanine (Tpa) in the E. coli genome [62]. Working on a tryptophan auxotrophic E. coli
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strain, selection was carried out by lowering indole (tryptophan precursor) while maintaining high beta-thieno[3,2-
b]pyrrole concentrations. After 264 passages E. coli strains were isolated that could use Tpa or tryptophan in their
proteomes, thus engineering a viable degeneracy. While it would not be possible to exploit this degeneracy for con-
tainment by genetic code expansion, it could be used as a wedge, progressively altering the organism’s large aromatic
amino acid requirement to the point that tryptophan could no longer rescue the strain.
Semantic containment when enforced through the use of ncAAs, actually impose a double containment: the in-
formation is trapped in the altered genetic code and the host is trapped by a de facto auxotrophy for the ncAA. The
contribution of each measure towards containment can be deconvoluted by also engineering pathways for the in vivo
synthesis of the ncAA being used. For instance, Mehl and colleagues [63] introduced a Streptomyces venezuelae
metabolic pathway capable of synthesizing p-aminophenylalanine (pAF) into an E. coli strain capable of incorpo-
rating pAF in response to an amber stop codon using an engineered orthogonal TyrRS/tRNA pair. The result was a
prototroph with an expanded genetic code – one where the impact of semantic containment can be studied separately
from the auxotrophic one.
A similar situation (albeit on a different order of magnitude in terms of complexity) could be achieved by inverting
the chirality of biology. Although current biology is based on L-amino acids andD-sugars, life would be possible (and
equally efficient) in the opposite combination (D-amino acids and L-sugars) – a ‘mirror’ life [64,65].
Engineering further containment: genetic
containment
Life on Earth is underpinned by nucleic acids. The two natural backbones, deoxyribonucleic acid (DNA) and ribonu-
cleic acid (RNA), are biopolymers made from a limited set of possible nucleotide precursors; variants of a common
chemical structure: a phosphate group that is linked to a nitrogenous base via a 5-carbon sugar linker. The fact that
modern, naturally occurring genetic systems are all based onDNAandRNAdoes notmean that other chemical forms
of genetic information storage are not conceivable. With the aim of finding novel building blocks for the design of
artificial nucleic acids, each of the three components of natural nucleotides has been iteratively replaced by alternative
chemical structures renderingwhat has been defined as ‘xeno–nucleotides’ [66].Modifications to the canonical struc-
ture of nucleotides have resulted in numerous variants presenting: unnatural nucleobases, alternative base-pairings,
novel cyclic or even acyclic sugar backbones, and altered phosphate groups or alternative leaving groups. In depth
reviews regarding the different chemistries developed so far can be found in [67–69].
A subset of the available chemistries has even been successfully polymerized intoXenobioticNucleic Acids (XNAs).
Some of these XNAs allowed duplex formation [67] and information storage [70,71], and were even evolved into
functional molecules such as aptamers and XNAzymes [70–73]. These results suggest that DNA and RNA are not, in
principle, the only genetic polymers capable of sustaining life, and so life based on XNAs may also be thinkable.
To date, no life on Earth has been reported to use XNA for genetic information storage and it is unclear whether
biology would be able to access the information within it. If not, then the biocontainment of a GEM carrying XNA
as genetic material could be feasible. Prevention of horizontal gene transfer to nature could arise from the genetic
isolation of XNA-based GEMs. As replication, transcription or incorporation of an XNA into the genome of GEM’s
natural counterparts would be prevented, a ‘genetic firewall’ could be raised between nature and genetic engineering.
Before even envisaging aGEMbuilt uponXNA, a simpler first approach to develop and test a genetic firewall would
be to create an XNA-based replication unit (e.g. episome) that can be maintained in a bacterial cell independently
from itsDNAgenome (Figure 3). Any desired trait could be engineered into theXNAepisomewhile theDNAgenome
would only be used for chassis maintenance. In order to set up an XNA-episome replication system in vivo there are
several characteristics that the XNA, the episome itself and the host cell must fulfil (adapted from [74]):
 Regarding the potential XNA,
1) to ensure cell survival, the XNA cannot be toxic in any way, be it as precursor, triphosphate, polymer or degra-
dation products.
2) to allow an initial transference of information from natural nucleic acids and vice versa, a dedicated XNA
synthetase and XNA reverse-transcriptase should be available.
3) to attain orthogonality (complete isolation from the DNA/RNA genetic system), the XNA should not be inter-
preted by the host cell replication or transcription machinery.
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Figure 3. An orthogonal replication system for genetic containment
An XNA genetic element (in orange) is maintained by the external provision of xenobiotic nucleoside triphosphates (xNTPs) or cell-permeable
precursors (yellow) and replicated by means of an engineered XNA-dependent XNA polymerase (or XNA replicase) and accessory proteins
(in purple). Selection of the synthetic episome across generations occurs by encoding a vital gene product or functional XNA in the episome
itself. In either case, an XNA-directed RNA polymerase is necessary (in purple). Prevention of cross-talk with the natural DNA genetic system
(in green) is essential to create a stable XNA system and to establish an effective genetic firewall (dotted line).
 Regarding the EPISOME,
4) to guarantee maintenance in controlled culture conditions, one selectable function indispensable for growth
must be encoded in the XNA episome (like antibiotic resistance is encoded in commercial plasmids):
4.1) if the selectable marker encodes an mRNA that is destined to be translated into an essential protein (e.g.
detoxification of an antibiotic), then a dedicated RNA polymerase is required.
4.1) if the selectable marker is a functional XNA, this molecule would need to perform a metabolic action
vital to the host cell (e.g. XNA molecule that binds and inactivates a small toxic RNA). Such functional
XNA must be developed and crucially, any function must be restricted to XNA – the same sequence in a
different chemistry cannot rescue selection.
5) to replicate the XNA episome across generations, a dedicated XNA replicase, XNA helicase and XNA single-
strand binding protein should be encoded in the episome.
6) to retain orthogonality, XNA enzymes should not accept natural nucleic acids as substrates.
 Regarding theHOST CELL (e.g. E. coli),
7) to prevent replication in non-controlled conditions, XNA precursors cannot be made in the cell. Cells must be
auxotrophic for the XNA building blocks.
8) to provide cells with XNA precursors, a natural or engineered mechanism for the uptake should exist.
There is a remaining point, regarding the destiny of xeno-nucleotides in vivo that has not been included in the list
because it does not represent an essential item to establish an XNA episome, but requires attention. Natural nucleic
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acids are synthesized using nucleoside triphosphates as monomers. However, only the nucleoside monophosphate
ends up being incorporated into the DNA or RNA molecule while the remaining pyrophosphate, necessary for the
activation of the monomer, is released as a secondary product. As the pyrophosphate is not included in the final
biopolymer it is known as the ‘leaving group’. Pyrophosphate is further hydrolysed to release two molecules of phos-
phate. In nature, no exception to the usage of pyrophosphate as the leaving group has ever been reported. It has been
pointed out that it would be difficult to install xeno-nucleoside triphosphates in a cell environment without inter-
fering with DNA and RNA metabolism, cell energy supply [adenosine triphosphate (ATP) levels] or substrate-level
phosphorylation (due to the free available phosphate) [74]. One way to overcome this problem would be to use a
different type of leaving group in the precursors for the enzymatic synthesis of the XNA. Different chemistries for
alternative leaving groups, based on L-amino acids, phosphono-L-Ala or iminodiacetate, have been suggested and
studied [75], however the enzymes capable of efficiently incorporating the nucleoside monophosphates out of the
alternative nucleotides have yet to be developed.
Potential XNA-episome chemistries –
sugar-modiﬁed nucleic acids
Based on the conditions described in the previous section for an XNA to embody an episome in vivo, we describe a
group of potential candidate chemistries that have the potential to fulfil conditions described in one to three above.
The sugar moiety of natural nucleotides has been extensively modified. Changes in functional groups, size and iso-
merization states (including cyclical and linear linkers) have been explored returning the following candidate XNAs:
anhydrohexitol nucleic acid (HNA) [76], threose nucleic acid (TNA) [77], glycerol nucleic acid (GNA) [78], cyclo-
hexene nucleic acid (CeNA) [79] and locked nucleic acid (LNA) [80,81].
In order to study the physico-chemical and biological properties of the XNAs, a mechanism of polymerizing
xeno-nucleotides is necessary. Polymerization can occur chemically, through solid-phase synthesis, or enzymatically
via polymerases. Chemical polymerization of xeno-nucleotides is generally effective enough for assembling short
oligomers. On the other hand, natural polymerases have a stringent substrate specificity that prevents the efficient
incorporation of chemically modified nucleotides. Thus, in order to study the potential applications of XNAs it is
always necessary to develop the enzymatic machinery that can cope with XNA polymerization and XNA interpreta-
tion (i.e. information propagation). The way to do this is either by screening natural polymerases for such activity, or
by engineering known polymerases through rational design or directed evolution. An example of engineering is the
Archaean 9◦N DNA polymerase that was originally modified by the introduction of the A485L mutation (commer-
cially known as Therminator, New England BioLabs, Inc. [82]) to incorporate a wide range of unnatural nucleotides.
Under optimal conditions and provided that no long poly-G stretches are present, this enzyme is capable of copying
DNA templates into TNA with high fidelity [83]. On the other hand and as a result of polymerase screening, TNA
retro-transcriptase activity was discovered in the wild-type DNA polymerase I of Geobacillus stearothermophilus
(Bst) showing about 60% full-length conversion of TNA into the complementary DNA product [84].
In a more extensive work of engineering carried out by directed evolution and the application of a novel in vitro
selection platform, a different Archaean polymerase from Thermococcus gorgonarius (TgoT) was evolved into a
synthetase able to transcribe long stretches of DNA into HNA (Pol6G12) [71]. The selection also provided two other
enzymes (PolC7 and PolD4K) with broader substrate specificity capable of synthesizing CeNA and LNA among other
chemistries [71]. In order to reverse transcribe the XNA polymers back into DNA, TgoT was also engineered by
rational design into two retro-transcriptases able to copy HNA and TNA (RT521) or CeNA and LNA (RT521K)
back into DNA [71]. This was a step forward in the study of XNAs, not only because several novel enzymes were
engineered but also because an in vitro platform for the selection of XNA polymerases – adaptable to other XNA
modifying enzymes – was devised, opening the possibility of the evolution of more enzymes of interest such as XNA
replicases, XNA-directed RNA polymerases, XNA ligases and XNA polinucleotide kinases [85].
At a translational level, the compatibility of the above XNAs with the protein synthesis machinery of E. coli has
only been tested for HNA [86]. A short messenger RNA was designed, with the first and second codons replaced
by HNA. Efficient peptide formation and translocation was observed in translation experiments performed in vitro.
Ribosomal binding of the messenger and tRNA incorporation showed no differences between a fully RNA molecule
and the HNA/RNA hybrid described [86].
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Potential XNA-episome chemistries –
modiﬁed nucleobases and alternative
base-pairings
Adifferent category of xeno-nucleotides is defined by those carrying nucleobasemodifications, resulting in the diver-
sification of nucleotide pairing schemes beyond those known to nature and described by Watson and Crick. Natural
nucleobases are paired based on the rules of size complementarity (large purine pairs with small pyrimidines) and
hydrogen-bonding complementarity (hydrogen-bond donor pairs with hydrogen-bond acceptors). However, if the
hydrogen-bond donating and acceptor groups are shuffled, eight novel nucleobases capable of forming four addi-
tional base-pairs with the same geometry as A:T and C:G pairs could be envisaged. This was the work pioneered
by Yang and colleagues, who described a family of nucleoside analogues, and probed that at least two of them (triv-
ially called dP:dZ) could be a suitable alternative base-pair in vitro [87]. The artificial dP (2-aminoimidazo[1,2-a]-
1,3,5-triazin-4(8H)-one) and dZ (6-amino-5-nitro-2(1H)-pyridone) nucleotides are able to pair with three hydrogen
bonds and standard Watson–Crick geometry. TheThermus aquaticus DNA polymerase was engineered to improve
the synthesis of a nucleic acid containing both dP and dZ along with the four canonical dNTPs (ATCGPZ DNA) [88].
When incorporated into DNA the unnatural base-pair is polymerase chain reaction (PCR) amplifiable with a fidelity
of 99.8% [89]. The ribonucleotide versions of dP and dZ (rP and rZ, respectively) were also synthesized and effi-
ciently incorporated into RNA using T7 RNA polymerase. To retrieve the information back into an ATCGPZ DNA
molecule, a superscript reverse-transcriptase was used [90]. Incorporation of these nucleotides into DNA or RNA,
still allows the formation of a double-helix structure for both molecules [91]. The use of DNA containing codons
based on an expanded genetic alphabet opens the possibility of establishing an expanded translation system that also
allows the incorporation of ncAAs into proteins.
Another strategy for alternative base-pairing relies on the development of size-expanded nucleotides. By the addi-
tion of a benzene ring, both purines and pyrimidines can be expanded by 2.4 A˚, and when paired to dNTPs they still
enable the formation of a double helix. The resulting molecule, called xDNA, is wider than the natural double helix
and has a higher stability than a DNA of analogous sequence, mostly due to the enhanced stacking of the enlarged
nucleobases [92]. xDNAwas evaluated for its ability to function like a genetic system in vivo [93]. Plasmids encoding
green fluorescent protein were constructed to contain up to eight xDNA bases and were transformed into E. coli. All
four xDNA bases were found to pair correctly in the replicated plasmid DNA, and also permitted the expression of
the fluorescent protein, turning colonies green. Based on the evidence, xDNA could function as an artificial genetic
system, however the enzymatic machinery able to efficiently polymerize these nucleotides is yet to be developed.
When it comes to artificial nucleobases, complementary hydrogen bonding is not a condition for the efficient and
selective replication of DNA [94]. Metal-dependent pairing as well as hydrophobic and packing forces (including
ring-stacking) have been explored [95,96]. Two promising candidates for an alternative base-pairing system based
on hydrophobic nucleotides have been described (d5SICS-dNaM and d5SICS-dMMO2). Both artificial pairs are ef-
ficiently transcribed in both directions [97] and can be amplified by PCR [98]. A crystal structure of a KlenTaq DNA
polymerase bound to a DNA containing the pair dNaM-d5SICS showed that the structure adopted by the modified
nucleobases is co-planar with nearly optimal edge-to-edge, similar to what is observed in DNA [99].
In order to test how feasible it would be to expand an organism’s genetic alphabet in vivo, Malyshev and colleagues
designed a system for E. coli based on the incorporation and replication of the dNaM-d5SICS nucleotide pair. E.
coli was transformed with two plasmids, one carrying a gene for the expression of a heterologous nucleoside triphos-
phate transporter for the active uptake of dNaM and d5SICS, and a second plasmid carrying a sequence with the
six-letter code (dA, dT, dC, dG, dNaM and d5SICS) to work as a template for replication. In what represented a major
breakthrough in the field, both modified nucleotides were taken up from the culture media, efficiently incorporated
into the newly synthesized copies of plasmid, and remained untouched by the E. coli DNA repair mechanisms for
about 24 generations (17h) [100]. This work can now be expanded to integrate the modified base-pairs into other
cellular processes such as translation – as demonstrated by Fukunaga and colleagues for a different set of unnatural
nucleobases [101].
However, whether XNAs will be able to sustain life is still an open question. In this regard and in contrast withmost
of the studies performed so far, Marlie`re and colleagues carried out a top-down experiment designed to perform the
DNA transliteration of the entire E. coli genome. A strain deficient in the synthesis of thymine nucleotides was cul-
tured in the presence of 5-chlorouracil as an alternative and artificial nucleobase precursor. After 1000 generations and
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more than 1500 mutations, an adapted strain that grew only with 5-chlorouracil was recovered. Its genome contained
90% of the 5-chlorodeoxyuridine and 10% of the thymidine, which was later reduced to 1.5% (the limit of detection)
by disrupting a secondary pathway for the synthesis of thymidine based on S-adenosylmethionine [102]. To date, this
is the sole report of an organism whose genome carries a modified nucleotide in place of a natural one, suggesting
that XNA-based life is possible.
Minimal genomes
There is a different subfield in synthetic biology that works at thewhole genome level. Current approaches on genome-
driven cell engineering aim to develop functioning minimal genomes that only contain the genes that are necessary
to sustain life. The development of minimal genomes entails the screening of natural genomes to find candidates that
could be then devoid of non-essential genes. The aim is to create a simple standardized host cell that would allow
the implantation of synthetic biology devices. Although chromosomes in here are still envisaged as DNA based, a
minimized genome should limit the potential of the host to adapt to a different environment and growth conditions.
Thus, the likelihood of perpetuating and evolving if the microbe is released into the environment would be reduced
[103]. In this regard, an engineering strain of Mycoplasma mycoides bacterium with the smallest genome and the
fewest genes of any freely living organism was reported earlier this year [104]. This newly engineered organism was
named Syn 3.0 and it has a genome that was reduced to 473 genes required to survive and reproduce. Syn 3.0 colonies
are morphologically similar to those of the original cell although smaller, probably due to its slower growth rate (Syn
3.0 doubling time is three hours in comparison with one hour for the original cell).
The arrangement of a minimal DNA genome carrying only ‘housekeeping’ genes combined with an XNA-based
episome engineered to provide traits of interest would allow the development of enhanced safeguard systems.
Mechanistic containment
A final approach to biological containment is the development of genetic elements that require mechanisms or-
thogonal to the host to be viable. In a basic sense, mechanistic orthogonality pertains to the inability of some
natural enzymes (e.g. polymerases) or even higher complexes (e.g. ribosomes) to access foreign – natural or
synthetic – substrates.
Examples of natural genetic elements that are mechanistically orthogonal to the cellular genetics include many
phage and viral chromosomes, which are replicated only by means of their self-encoded polymerases [105]. Host-cell
polymerases are subjected to mechanistic inhibition, as they are unable to initiate replication of the foreign genetic
unit. This can be adapted for containment by establishing systems where the replicase is provided in trans. Though its
efficiency would be presumably lower than other genetic or semantic containment, mechanistic orthogonality could
be an enabling tool for both of these.
All three of the fundamental processes of the central dogma – DNA replication, transcription and translation – are
most highly regulated at the stage of initiation [106–110]. Initiation is themajor targeting step for signalling pathways
triggered by stress factors, such as heat shock and pathogens. This is most probably related to the high energetic cost
these processes have (especially translation). The burden of placing regulatory checkpoints too far downstreamwould
be not viable due to the associated metabolic cost.
Consequently, it is possible to engineer systems that rely on orthogonal modes of initiation of the replication or
expression processes (e.g. T7 transcription, see below). A system like this would allow an engineered enzyme to
catalyse an early-stage step on a foreign target that would otherwise be inaccessible to the host. If the survival of the
host is then linked to its ability tomaintain a foreign episome and transcribe a foreign open reading frame, or translate
a foreign mRNA, it would be possible to develop cells with a second pool of genetic material and/or ribosomes.
However, few such systems exist, and many retain a high level of cross-talk with native substrates. For instance,
as described in previous sections, several polymerases have been engineered to incorporate xNTPs at the elongation
stage. For in vivo applications, however, the currently available enzymes are not suitable, as they tend to retain activ-
ity on their natural substrates, and in many cases this outcompetes the XNA synthesis activity (C. Cozens and V.B.
Pinheiro, personal communication). Thus, incorporating orthogonality into the initiation step would be essential to
separate the activity of an engineered enzyme from its natural substrate, preventing cross-talk with host substrates.
Such isolation is important in synthetic biology because it allows the isolated system to be engineered without a sig-
nificant impact on the rest of the cell. In the case of an orthogonal episome, this would imply being able to engineer
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
Licence 4.0 (CC BY).
403
Essays in Biochemistry (2016) 60 393–410
DOI: 10.1042/EBC20160013
enzymes, cofactors and open reading frames encoded in the episome free from the burden of having to sustain the
host. As a result, such isolated systems could be more readily engineered (i.e. with fewer evolutionary constraints)
than systems that are required for host survival.
Orthogonal replication as a containment
strategy
The simplest systemof this kind is therefore one inwhich a foreign episome is replicated by an orthogonalmechanism,
as described previously in the genetic containment section.
The most commonly used genetic elements in E. coli molecular biology are plasmids. However, for the purposes
of containment, they do not allow orthogonality as they are replicated by host factors [111].
In recent years, two replication systems for linear chromosomes that are independent of the host enzymaticmachin-
ery have been characterized and assembled. These are the replisome of the bacteriophage phi29 that infects Bacillus
subtilis [112] and the selfish replicating system of the linear plasmids pGKL1 and pGKL2, which infect certain strains
of the yeast Kluyveromyces lactis [113]. Both systems utilize a polymerase that exclusively replicates linear genetic
elements with the aid of certain accessory proteins such as priming proteins (also known as terminal proteins or TP),
and single-strand and double-strand DNA binding proteins [114,115]. The phi29 DNA polymerase does not initiate
replication from an RNA primer but from the serine hydroxyl-group of the TP protein [116]. In infected cells, the
polymerase exists as a dimer with TP [117,118] and only dissociates after initiation, when the TP remains covalently
attached to the end of the phage genome. Although in vitro the polymerase can extend a primer on a single-stranded
template, its efficiency is reduced in the absence of its accessory proteins (single-strand and double-strand DNA
binding proteins and TP) [112].
A phi29 replisomewould be powerful in vivo since in the presence of TP, the polymerase can be exclusively targeted
to the replication of linear genetic elements that are capped by TP. Though the system is not yet adapted for the in vivo
replication of heterologous elements, it is a potential platform for the development of orthogonal genetic elements.
An alternative phi29 in vitro episome has been developed based on rolling circle amplification, but it cannot in its
current state be used for in vivo applications, since DNA replication does not regenerate the discrete genomes like
the input genome (input: single-stranded circular; output: single-stranded linear), and is not orthogonal as it is able
to use primers generated by RNA polymerases [119].
In the case of the K. lactis pGKL1/2 system, which is expected to replicate its genome in a similar way to phi29
[113], there is an additional physical separation in the infected cells between the plasmid genome in the cytosol and
the host genome in the nucleus. The encapsulation of cellular processes within membranous compartments such as
the nucleus allows the spatial separation – or compartmentalization – of the host genome from the secondary epi-
some. This or similar methods could therefore also contribute to the orthogonality of engineered episomes based on
alternative genetics, where it may be essential to avoid cross-talk, especially of the engineered polymerases (see ge-
netic containment; point 6). Alternative compartmentalization schemes include proteinaceous microcompartments,
in which a number of metabolic pathways have been engineered [23].
Orthogonal translation as a containment
strategy
As found in transcription, where promoters and polymerases can be modified to be orthogonal to the host systems
(discussed above), regulatory elements in translation and the cellular translation machinery itself can be engineered
to isolate a circuit from wider biology.
Translation initiation in prokaryotes is regulated by the binding of the 30S ribosomal subunits (with associated
initiation factors) to ribosomal binding sites (RBSs, also known as Shine-Dalgarno sequences), located within the
substrate mRNA upstream of initiation codons [120,121]. RBS sequences are reverse complementary to the 3’-end of
the 16S ribosomal RNA of the 30S subunits (the anti-SD) and rely on base-pairing for the initial interaction. Rack-
ham and Chin exploited that requirement to diversify anti-SD sequences in the 30S of ribosomes, isolating variants
(O-ribosomes) with modified RBS requirements that could not initiate translation from the canonical RBS (i.e. were
orthogonal to the biological system) [122].
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Freed from their biological roles, these ribosomes have been exploited to increase yields obtained from ncAA-
containing protein synthesis [123] as well as to further engineer the ribosome itself [48,124–126] – with a potential
impact on genetic code engineering (see below).
Being more complex than its bacterial counterpart, the eukaryotic translation system may provide additional po-
tential processes that can be targeted for containment by creating a platform that can coexist but not interact with
the natural cellular processes. Although no orthogonal ribosome has been isolated in eukaryotes, there is mounting
evidence that there are distinct populations within cells [127,128] and that they can be engineered [129].
An alternative approach is to engineer the reading window required by the ribosome. Although the genetic code
is exclusively based on triplet codons, a number of tRNA variants have been reported that induce a frameshift when
incorporated in translation (see Figure 2) [130–133]. These variants expand the tRNA contact with themRNA leading
to a quadruplet codon, which can be incorporated by natural systems in some sequence contexts and may provide
the host with a marginal evolutionary advantage by increasing the coding potential of some of its genes [134–136].
Quadruplet codons have been exploited for the incorporation of ncAAs in proteins [124,137] and their incorpo-
ration can be further improved by engineering the ribosome itself [48,123]. Quadruplet codons not only increase
the available genetic code (256 rather than 64 possible variations) but could also have a role in containment where
this mechanistic containment would also generate a semantic containment with the synthesis of functional proteins
dependent on a codon space not naturally available.
Conclusions
The synthetic biology industry is one of the fastest growing industries, projected to be worth 5 billion dollars by 2018
[138], with chemicals, pharmaceuticals, energy and agriculture, as somemajor applicationmarkets. The increased re-
liance on biology as an industrial tool, together with the potential to synthesize organisms from scratch, decreases the
probability that we understand and can predict every possible interaction between engineered hosts and the environ-
ment. For the sustained growth of the bioeconomy and for our own safety, it is important that biocontainment evolves
from tackling the known risks to pre-empting unknown risks and routes of escape. In order to develop containment
mechanisms built-in within the GEM itself, synthetic biology has deployed a collection of tools that are driving the
design of a new generation of biocontainment strategies. These mechanisms intend to be not only more effective
than previous strategies but also potentially intercompatible. There is agreement in the synthetic biology commu-
nity that multiple and redundant systems of biocontainment are necessary to prevent escapes, with containment not
resting on any single component that can be bypassed by inactivation (i.e. by mutations) [139]. The development of
multi-layered control systems that can coexist within a single engineeredmicroorganism should hopefully reduce the
probability of an escape to negligible levels. We are still some way from robust orthogonal systems that can be used
for practical applications; not only does the enzymatic machinery necessary to deal with these artificial systems still
need to be designed, but true orthogonality via the development of “no cross-talk” firewalls also has to be guaranteed.
Summary
• Biology is not limited bywhat is natural but bywhat is possible. Life emerged from the chemistry permissible
by available substrates. Natural evolution builds on that, with rare instances of innovation and multiple
instances of optimization. Consequently, it is possible to engineer a biological system to access unnatural
substrates or generate unnatural products, which may be of value to humanity (e.g. novel materials, anti-
cancer or antimicrobial compounds or biofuels).
• Genetically engineered microorganisms (GEMs) present two potential environmental hazards, ecological
or informational, depending on whether the organism can become established in an ecological niche or its
genetic information can be transferred to a natural host.
• Risk can be accurately measured only if all possible failure modes and their probabilities of occurrence are
known.
• Biological containment is a long-standing concern for scientists. A number of containment strategies
have been developed and are widely used by the academic and industrial communities. These are centred
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primarily around physical barriers, use of microorganisms with decreased fitness and genetic circuits that
limit the escape of genetic information.
• All biological processes can be altered to establish systems that do not exchange information with nature,
be it genetic information storage, its maintenance, protein translation or even the cell’s metabolism. These
orthogonal systems can be the basis of a new generation of biological containment strategies where both
organism and information are isolated from the environment and unable to interact with biology.
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